 | Up a level |
Journal Article
Hyman, David M., Tran, Ben, Paz-Ares, Luis, Machiels, Jean-Pascal, Schellens, Jan H., Bedard, Philippe L., Campone, Mario, Cassier, Philippe A., Sarantopoulos, John, Vaishampayan, Ulka, Chugh, Rashmi, Mahipal, Amit, Lockhart, A. Craig, Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe 
ORCID: 0000-0003-1781-2518, Bendiske, Jennifer, Chen, Xueying, Choudhury, Somesh, Graus-Porta, Diana, Lewis, Nancy, Perez Garcia, Jose Manuel and Jose de Miguel-Luken, Maria
(2019).
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations.
JCO Precis. Oncol., 3.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 2473-4284
Nogova, Lucia, Sequist, Lecia V., Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H. M., Cassier, Philippe A., Camidge, D. Ross, Schuler, Martin, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Burris, Howard, Tian, G. Gary, Campone, Mario, Wainberg, Zev A., Lim, Wan-Teck ORCID: 0000-0002-4655-0206, LoRusso, Patricia, Shapiro, Geoffrey I., Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard and Wolf, Juergen
(2017).
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.
J. Clin. Oncol., 35 (2).
S. 157 - 176.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grunwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus and Bajorin, Dean F.
(2018).
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Cancer Discov., 8 (7).
S. 812 - 822.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 2159-8290
Pal, Sumanta K., Rosenberg, Jonathan E., Keam, Bhumsuk, Wolf, Juergen, Berger, Raanan, Dittrich, Christian, Hoffman-Censits, Jean H., Quinn, David ORCID: 0000-0002-1411-0417, van der Noll, Ruud, Burris, Howard A., Galsky, Matt D., Gravis, Gwenaelle, Lee, Jae-Lyun, Medioni, Jacques, Mortazavi, Amir, Maroto, Pablo, Parker, Katie, Chen, Xueying, Isaacs, Randi and Bajorin, Dean F.
(2016).
Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755